Carregant...
Membrane Phospholipids, EML4-ALK and Hsp90 as Novel Targets in Lung Cancer Treatment
Approximately one third of patients with non-small cell lung cancer have unresectable stage IIIA or stage IIIB disease; combined cytotoxic chemotherapy and radiation therapy delivered concurrently has been established as the standard treatment for such patients. Despite many clinical trials testing...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3718064/ https://ncbi.nlm.nih.gov/pubmed/23708071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0b013e31829a68eb |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|